PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Carbomer - Dry eyes

PAD Profile : Carbomer - Dry eyes Important

Keywords :
Tear deficiency, dry-eyes, eye lubicants, ocular lubricants, dry eye disease, dry eye syndrome, carbomer eye drops, carbomer eye gel
Important Information :
Mild / moderate dry eye. Prescribe by brand (primary care)

Traffic Light Status

Status 1 of 3.

Status :
Green
Important
Formulations :
  • Eye drops
  • Eye gel
Important Information :
1st line: Aacomer 0.2% eye gel or Aacarb Carbomer 0.2% eye gel 2nd line: Clinitas carbomer 0.2% eye gel or Lumecare carbomer 0.2% eye gel
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 3.

Status :
Green
Important
Formulations :
  • Eye drops (preservative free)
Important Information :
1st line = Evolve Carbomer 980 prefervative free 0.2% eye gel 2nd line = Xailin 0.2% eye gel
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 3 of 3.

Status :
Green (see narrative)
Important
Formulations :
  • Eye drops (unit dose)
Important Information :
Prescribe as Ocu-Lube Carbomer 0.2% Reserved for occasional use where unit dose is required (e.g. to carry in a bag)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Type
Document
Review Date
Patient resource
03 June 2026

Committee Recommendations

No committee recommendations returned.

Associated BNF Codes

11. Eye
11.08.01. Tear deficiency, eye lubricant and astringent
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More